This finding suggests that CAFs expressing high levels of BMPR1B may be more responsive to BMP signaling, which subsequently modulates the rigidity of CAFs, stiffness of the tumor microenvironment, and CD4_4 T cell trafficking. The gene discussed is BMPR1B; the disease is neoplasm.